Ledipasvir and sofosbuvir tablets, for oral use.
Indication:
HARVONI is indicated with or without ribavirin for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1, 4, 5, or 6 infection
Active principle: Ledipasvir , Sofosbuvir
HARVONI®
Partner: GILEAD SCIENCES - SHTETET E BASHKUARA TE AMERIKES